|
|
Volumn 5, Issue 1, 1996, Pages 115-124
|
|
Recent advances in HIV-1 protease inhibitors
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
3 [3 (4 CYANOBENZENESULFONAMIDO) ALPHA CYCLOPROPYLBENZYL] 4 HYDROXY 2 OXOCYCLOOCTA[E]PYRAN;
4 HYDROXY 6 (1 ETHYL 2 PHENYLETHYL) 3 (1 PHENYLPROPYL) 2 PYRONE;
4,7 DIBENZYL 2,3,4,5,6,7 HEXAHYDRO 5,6 DIHYDROXY 1,3 BIS[4 (HYDROXYMETHYL)BENZYL] 2H 1,3 DIAZEPIN 2 ONE;
A 77003;
A 80987;
AG 1284;
AMPRENAVIR;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ANTIVIRUS AGENT;
CGP 53437;
CGP 57813;
DIDANOSINE;
HOE BAY 793;
INDINAVIR;
KYNOSTATIN 272;
MOZENAVIR;
NELFINAVIR;
PEPTIDE DERIVATIVE;
PROTEINASE;
PROTEINASE INHIBITOR;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
SAQUINAVIR;
SDZ PRI 053;
STAVUDINE;
TELINAVIR;
U 103017;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VIRUS ENZYME;
XM 412;
ZALCITABINE;
ZIDOVUDINE;
ANIMAL MODEL;
ANTIVIRAL ACTIVITY;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG POTENTIATION;
DRUG RESISTANCE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LIVER DYSFUNCTION;
MULTIDRUG RESISTANCE;
NEPHROLITHIASIS;
NONHUMAN;
REVIEW;
VIRUS MUTANT;
|
|
EID: 0030046136
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.5.1.115 Document Type: Review |
|
Times cited : (17)
|
|
References (0)
|
